Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$208K Sell
2,551
-3,540
-58% -$280K ﹤0.01% 1269
2026
Q1
$445K Buy
6,091
+740
+14% +$57.6K 0.01% 909
2025
Q4
$410K Buy
+5,351
New +$404K 0.01% 911
2025
Q2
Sell
-2,922
Closed -$276K 1261
2025
Q1
$276K Sell
2,922
-868
-23% -$91.8K 0.01% 969
2024
Q4
$417K Buy
3,790
+406
+12% +$46.5K 0.01% 857
2024
Q3
$436K Sell
3,384
-819
-19% -$95.3K 0.01% 793
2024
Q2
$519K Buy
4,203
+819
+24% +$103K 0.01% 756
2024
Q1
$436K Sell
3,384
-110
-3% -$13.4K 0.01% 792
2023
Q4
$431K Buy
3,494
+494
+16% +$52.6K 0.01% 783
2023
Q3
$307K Buy
3,000
+696
+30% +$72.7K 0.01% 798
2023
Q2
$231K Buy
2,304
+355
+18% +$35.5K 0.01% 868
2023
Q1
$200K Sell
1,949
-14
-0.7% -$1.51K 0.01% 898
2022
Q4
$202K Buy
+1,963
New +$199K 0.01% 830

Other funds holding IOSP

Ethic Inc's IOSP Position: Q2 2026 in Review

Ethic Inc reduced its Innospec (IOSP) stake by 58% in Q2 2026, selling an estimated $280K and leaving 2,551 shares worth $208K. The position accounts for ﹤0.01% of the portfolio, ranked #1269.

Ethic Inc first reported a position in IOSP in Q4 2022 and has held it in 13 quarters since. The position peaked at $519K in Q2 2024. 281 funds tracked by Wall St. Rank hold IOSP as of Q2 2026.

  • Ethic Inc held 2,551 shares of Innospec worth $208K as of Q2 2026.
  • Ethic Inc sold 3,540 Innospec shares in Q2 2026, an estimated $280K.
  • Innospec made up ﹤0.01% of Ethic Inc's portfolio in Q2 2026, its #1269 holding.
  • Ethic Inc first reported a position in Innospec in Q4 2022 and has held it in 13 quarters since.
  • Ethic Inc's Innospec position peaked at $519K in Q2 2024.
  • 281 funds tracked by Wall St. Rank held Innospec as of Q2 2026.

Based on Ethic Inc's 13F filing for Q2 2026, filed 29 Jul 2026.